I'm not sure if its feasable to produce a malaria "vaccine", however, if it's being tested on our Military personel, there must be a fair chance of success. If successful this stock should outperform.

Saw a sudden drop from $18 to $14 due to the stock caming in below earnings expectations. Appears, otherwise, to be a solid company and would expect it to go back to $18 fairly quickly. (Question:-- Was the sudden drop triggered by big institutions using computerized criteria for selling? Institutions own a significant percentage of this company.)

3:1 split If I'm reading my data correctly, this company has had a pretty steady cost per share over the years. If it spits and regains its current price, its pure profit. Problem is it will dilute current shares. (All guess work-wish those of us buying this stock luck.